Qiongzhi Wang - Cowealth Medical GM Director
| 603122 Stock | 7.23 0.14 1.90% |
Director
Qiongzhi Wang is GM Director of Cowealth Medical China
| Age | 68 |
| Address | Guangqi Building, Shanghai, China, 200233 |
| Phone | 86 40 0678 8855 |
| Web | https://ch.cowealth.com |
Cowealth Medical Management Efficiency
The company has return on total asset (ROA) of 0.0153 % which means that it generated a profit of $0.0153 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0243 %, meaning that it generated $0.0243 on every $100 dollars invested by stockholders. Cowealth Medical's management efficiency ratios could be used to measure how well Cowealth Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of March 24, 2025, Total Assets is expected to decline to about 1.4 B. In addition to that, Non Current Assets Total is expected to decline to about 182.9 MSimilar Executives
| Showing other executives | DIRECTOR Age | ||
| Jin Yang | Longxing Chemical Stock | 54 | |
| Baoliang Ma | Longxing Chemical Stock | 62 | |
| Liang Wei | Longxing Chemical Stock | 44 | |
| Hai Huang | Kunming Chuan Jin | 56 | |
| Feizhou Liu | Longxing Chemical Stock | 46 | |
| Liwen Wu | Shenzhen SDG Information | 57 | |
| Jia Wei | Kunming Chuan Jin | 55 | |
| Zequn Xiao | Liuzhou Chemical Industry | 59 | |
| Guoquan Sun | Nanning Chemical Industry | 40 | |
| Liping Long | Liuzhou Chemical Industry | 55 | |
| Zengmin Li | Shenzhen SDG Information | 46 | |
| Chao Chen | HengFeng Information Technology | 51 | |
| Ying Tao | HengFeng Information Technology | 54 | |
| Miaoxiu Guo | Nanning Chemical Industry | 43 | |
| Zhi Yang | HengFeng Information Technology | 50 | |
| Lewen Wu | Nanning Chemical Industry | 38 | |
Management Performance
| Return On Equity | 0.0243 | ||||
| Return On Asset | 0.0153 |
Cowealth Medical China Management Team
Elected by the shareholders, the Cowealth Medical's board of directors comprises two types of representatives: Cowealth Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cowealth. The board's role is to monitor Cowealth Medical's management team and ensure that shareholders' interests are well served. Cowealth Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cowealth Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Chen Zhang, CFO Supervisor | ||
| Ye Chen, Deputy Board | ||
| Qiongzhi Wang, GM Director |
Cowealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cowealth Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0243 | ||||
| Return On Asset | 0.0153 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 2.67 B | ||||
| Shares Outstanding | 398.05 M | ||||
| Shares Owned By Insiders | 57.57 % | ||||
| Shares Owned By Institutions | 0.63 % | ||||
| Price To Book | 2.46 X | ||||
| Price To Sales | 3.06 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Cowealth Stock
Cowealth Medical financial ratios help investors to determine whether Cowealth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cowealth with respect to the benefits of owning Cowealth Medical security.